•
Mar 31, 2023

DaVita Q1 2023 Earnings Report

DaVita's financial and operating results were announced for Q1 2023, with performance benefiting from an improving macro environment.

Key Takeaways

DaVita Inc. reported consolidated revenues of $2.873 billion, operating income of $312 million, and diluted earnings per share of $1.25 for the quarter ended March 31, 2023. The company's results benefited from an improving macro environment.

Consolidated revenues were $2.873 billion.

Operating income was $312 million, and adjusted operating income was $352 million.

Diluted earnings per share from continuing operations was $1.25, and adjusted diluted earnings per share from continuing operations was $1.58.

Operating cash flow was $463 million, and free cash flow was $265 million.

Total Revenue
$2.87B
Previous year: $2.82B
+2.0%
EPS
$1.58
Previous year: $1.61
-1.9%
US Dialysis Treatments
7.12M
Previous year: 7.11M
+0.1%
US Avg Treatments per day
92.43K
Previous year: 92.34K
+0.1%
US Revenue per Treatment
$366
Previous year: $361
+1.3%
Gross Profit
$815M
Previous year: $799M
+1.9%
Cash and Equivalents
$317M
Previous year: $328M
-3.2%
Free Cash Flow
$265M
Previous year: $147M
+80.3%
Total Assets
$16.7B
Previous year: $17.1B
-2.1%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2023 guidance for adjusted operating income from continuing operations to be between $1.475 billion and $1.625 billion, adjusted diluted net income from continuing operations per share to be between $6.20 and $7.30, and free cash flow to be between $750 million and $1.000 billion.

Revenue & Expenses

Visualization of income flow from segment revenue to net income